Herbal medicine for anxiety, depression and insomnia

Current Neuropharmacology

Volumn 13, Issue 4, 2015, Pages 481-493

  Liu, Lei ^a,b   Liu, Changhong ^a,b   Wang, Yicun ^a,b   Wang, Pu ^b   Li, Yuxin ^b   Li, Bingjin ^a,b  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

Depression; Herbal medicine; Insomnia; Mechanism; Psychopharmacology

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; ELONGATION FACTOR 2; NEUROPEPTIDE Y;

ANOXIA; ANXIETY DISORDER; ARTICLE; CHINESE MEDICINE; CIRCADIAN RHYTHM; DEPRESSION; FATIGUE; GINKGO BILOBA; HEPATITIS; HERBAL MEDICINE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSOMNIA; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRESS; UPREGULATION; ANIMAL; ANXIETY; ANXIETY DISORDERS; DEPRESSIVE DISORDER; SLEEP INITIATION AND MAINTENANCE DISORDERS;

ANIMALS; ANXIETY; ANXIETY DISORDERS; DEPRESSION; DEPRESSIVE DISORDER; HERBAL MEDICINE; HUMANS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84942105607     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X1304150831122734     Document Type: Article

References (155)

1. Murray, C. J., Lopez, A. D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet, 1997, 349 (9064), 1498-1504. http://dx.doi.org/10.1016/ S0140-6736(96)07492-2
2. Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J., Vos, T., Whiteford, H. A. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. Plos Med., 2013,10(11), e1001547. http://dx.doi.org/10.1371/journal.pmed.1001547
3. Diagnostic and Statistical Manual IV. American Psychiatric Press, Washington, D.C. 2000.
4. Baldessarini, R. J. Drug therapy of depression and anxiety disorders. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Edited by Brunton, L.L., Lazo, J.S., Parker, K.L. New York, McGraw-Hill, 2006, 429-460.
5. Kessler, R. C., Chiu, W. T., Demler, O., Walters, E. E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiat., 2005, 62(6), 617-627. http://dx.doi.org/10.1001/archpsyc.62.6.617
6. American Psychiatric Association. Diagnostic and Statistical Manual Of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association. 1994.
7. Morin, C. M., LeBlanc, M., Daley, M., Gregoire, J. P., Merette, C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med., 2006, 7(2), 123-130. http://dx.doi.org/10.1016/j.sleep.2005. 08.008
8. Ohayon, M. M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med. Rev., 2002, 6(2), 97-111. http://dx.doi.org/10.1053/smrv.2002.0186
9. Taylor, D. J., Lichstein, K. L., Durrence, H. H. Insomnia as a health risk factor. Behav. Sleep Med., 2003, 1(4), 227-247. http://dx.doi.org/10.1207/S15402010BSM0104_5
10. Baxter, A. J., Scott, K. M., Ferrari, A. J. Norman, R.E., Vos, T., Whiteford, H. A. Challenging the myth of an "epidemic" of common mental disorders: trends in the global prevalence of anxiety and depression between 1990 and 2010. Depress Anxiety, 2014, 31(6), 506-516 . http://dx.doi.org/10.1002/da.22230
11. Kessler, D., Bennewith, O., Lewis, G., Sharp, D. Detection of depression and anxiety in primary care: follow up study. BMJ, 2002, 325(7371), 1016-1017. http://dx.doi.org/10.1136/bmj.325. 7371.1016
12. Unutzer, J., Klap, R., Sturm, R., Young, A. S., Marmon, T., Shatkin, J., Wells, K. B. Mental disorders and the use of alternative medicine: results from a national survey. Am. J. Psychiatry, 2000, 157(11), 1851-1857. http://dx.doi.org/10.1176/appi.ajp.157.11.1851
13. Knaudt, P. R., Connor, K. M., Weisler, R. H., Churchill, L. E., Davidson, J. R. Alternative therapy use by psychiatric outpatients. J. Nerv. Ment. Dis., 1999, 187(11), 692-695. http://dx.doi.org/10. 1097/00005053-199911000-00007
14. Kessler, R. C., Soukup, J., Davis, R. B., Foster, D. F., Wilkey, S. A., Van Rompay, M. I., Eisenberg, D. M. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am. J. Psychiat., 2001, 158(2), 289-294. http://dx.doi.org/ 10.1176/appi.ajp.158.2.289
15. Pearson, N. J., Johnson, L. L., Nahin, R. L. Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 national health interview survey data. Arch. Inter. Med., 2006, 166(16), 1775-1782. http://dx.doi.org/10.1001/archinte.166. 16.1775
16. Hsu, M. C., Creedy, D., Moyle, W., Venturato, L., Tsay, S. L., Ouyang, W. C. Use of complementary and alternative medicine among adult patients for depression in Taiwan. J. Affect. Disord., 2008, 111(2), 360-365. http://dx.doi.org/10.1016/j.jad.2008.03.010
17. Tindle, H. A., Davis, R. B., Phillips, R. S., Eisenberg, D. M. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern. Ther. Health Med., 2004, 11(1), 42-49.
18. Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M., Kessler, R. C. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA, 1998, 280(18), 1569-1575. http://dx.doi.org/10. 1001/jama.280.18.1569
19. Kessler, D., Bennewith, O., Lewis, G., Sharp, D. Detection of depression and anxiety in primary care: follow up study. BMJ, 2002, 325(7371), 1016-1017. http://dx.doi.org/10.1136/bmj.325. 7371.1016
20. Butler, L., and Pilkington, K. Chinese herbal medicine and depression: the research evidence. Evid-Based Compl. Alt., 2013, 2013, 1-14.
21. Zhao, H., Wan, X., Chen, J. X. A mini review of traditional Chinese medicine for the treatment of depression in China. Am. J. Chinese Med., 2009, 37(02), 207-213. http://dx.doi.org/10.1142/ S0192415X09006771
22. Yeung, W. F., Chung, K. F., Ng, K. Y., Yu YM., Ziea ET., Ng BF. A. systematic review on the efficacy, safety and types of Chinese herbal medicine for depression. J. Psychiatr. Res., 2014, 57, 165-175. http://dx.doi.org/10.1016/j.jpsychires.2014.05.016
23. Yeung, W. F., Chung, K. F., Man-Ki Poon, M., Ho FY., Zhang SP., Zhang ZJ., Ziea ET., Wong VT. Chinese herbal medicine for insomnia: A systematic review of randomized controlled trials. Sleep Med. Rev., 2012, 16(6), 497-507. http://dx.doi.org/10.1016/j. smrv.2011.12.005
24. Ravindran, A. V. and da Silva, T. L. Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: A systematic review. J. Affect. Disord., 2013, 150(3), 707-719. http://dx.doi.org/10.1016/j.jad.2013.05.042
25. Belmaker, R. H., Agam, G. Major depressive disorder. New Engl. J. Med., 2008, 358(1), 55-68. http://dx.doi.org/10.1056/NEJMra 073096
26. Sulser, F., Watts, J., Brodie, B. B. On the mechanism of antidepressant action of imipraminelike drugs. Ann. N.Y. Acad. Sci., 1962, 96(1), 279-288. http://dx.doi.org/10.1111/j.1749-6632. 1962.tb50122.x
27. Hindmarch, I. Expanding the horizons of depression: beyond the monoamine hypothesis. Hum. Psychopharmacol., 2001, 16(3), 203-218. http://dx.doi.org/10.1002/hup.288
28. Lanni, C., Govoni, S., Lucchelli, A., Boselli, C. Depression and antidepressants: molecular and cellular aspects. Cell Mol. Life Sci., 2009, 66(18), 2985-3008. http://dx.doi.org/10.1007/s00018-009-0055-x
29. Lopez-Munoz, F., and Alamo, C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr. Pharm. Design, 2009, 15(14), 1563-1586. http://dx.doi.org/10.2174/138161209788168001
30. Xu, C., Teng, J., Chen, W., Ge, Q., Yang, Z, Yu, C., Yang, Z., Jia, W. 20 (S)-protopanaxadiol, an active ginseng metabolite, exhibits strong antidepressant-like effects in animal tests. Prog. Neuro-Psychoph., 2012, 34(8), 1402-1411. http://dx.doi.org/10.1016/j.pnpbp.2010.07.010
31. Zhang, M. Z., Zhang, Q. Y., Cui, G. B. Clinical study of XiaoYao-San in the treatment of depressive neurosis. J. Shandong Univ. TCM, 1998, 22, 34-37.
32. Xie, Z. L., Wang, X. H. Clinical study of Jiawei Sini Decoction in the treatment of 38 dysthymic patients. Chin. J. Inf. TCM, 2005, 12, 8-9.
33. Mao, Q., Huang, Z., Ip, S., Che, C. Antidepressant-like effect of ethanol extract from Paeonia lactiflora in mice. Phytother. Res., 2008, 22(11), 1496-1499.a.
34. Mao, Q. Q., Ip, S. P., Tsai, S. H., Che, C. T. Antidepressant-like effect of peony glycosides in mice. J. Ethnopharmacol., 2008, 119(2), 272-275.b.
35. Mao, Q. Q., Ip, S. P., Ko, K. M., Tsai, S. H., Xian, Y. F., Che, C. T. Effects of peony glycosides on mice exposed to chronic unpredictable stress: further evidence for antidepressant-like activity. J. Ethnopharmacol., 2009, 124(2), 316-320. http://dx.doi. org/10.1016/j.jep.2009.04.019
36. Lesch, K. P., Mossner, R. Knockout corner: 5-HT1A receptor inactivation: anxiety or depression as a murine experience. Int. J. Neuropsychoph., 1999, 2(04), 327-331. http://dx.doi.org/10.1017/ S1461145799001662
37. Kim, J. H., Kim, S. Y., Lee, S. Y., Jang, C. G. Antidepressant-like effects of Albizzia julibrissin in mice: Involvement of the 5-HT1A receptor system. Pharmacol. Biochem. Be, 2007, 87(1), 41-47. http://dx.doi.org/10.1016/j.pbb.2007.03.018
38. Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron, 2002, 34(1), 13-25. http://dx.doi.org/10.1016/S0896-6273(02)00653-0
39. Arborelius, L., Owens, M. J., Plotsky, P. M., Nemeroff, C. B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol., 1999, 160(1), 1-12. http://dx.doi.org/10. 1677/joe.0.1600001
40. Wu, J., Du, J., Xu, C., Le, J., Xu, Y., Liu, B., Dong, J. Icariin attenuates social defeat-induced down-regulation of glucocorticoid receptor in mice. Pharmacol. Biochem. Be, 2011, 98(2), 273-278. http://dx.doi.org/10.1016/j.pbb.2011.01.008
41. Kim, D. H., Moon, Y. S., Jung, J. S., Min, SK, Son, BK, Suh, HW, Song, DK. Effects of ginseng saponin administered intraperitoneally on the hypothalamo-pituitary-adrenal axis in mice. Neurosci. Lett., 2003, 343(1), 62-66. http://dx.doi.org/10.1016/S0304-3940(03) 00300-8
42. Duman, R. S., Heninger, G. R., Nestler, E. J. A molecular and cellular theory of depression. Arch. Gen. Psychiat., 1997, 54(7), 597-606. http://dx.doi.org/10.1001/archpsyc.1997.01830190015002
43. Altar, C. A. Neurotrophins and depression. Trends Pharmacol. Sci., 1999, 20(2), 59-62. http://dx.doi.org/10.1016/S0165-6147(99)01309-7
44. Murakami, S., Imbe, H., Morikawa, Y., Kubo, C., Senba, E. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci. Res., 2005, 53(2), 129-139. http://dx.doi.org/10.1016/j.neures.2005.06.008
45. Smith, M. A., Makino, S., Kvetnansky, R., Post, R. M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci., 1995, 15(3), 1768-1777.
46. Huang, E. J., Reichardt, L. F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci., 2001, 24, 677. http://dx.doi.org/10.1146/annurev.neuro.24.1.677
47. Castren, E., Rantamaki, T. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev. Neurobiol., 2010, 70(5), 289-297. http://dx.doi.org/10.1002/dneu.20758
48. Shirayama, Y., Chen, A. C. H., Nakagawa, S., Russell, D. S., Duman, R. S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci., 2002, 22(8), 3251-3261.
49. Duman, R. S., Vaidya, V. A. Molecular and cellular actions of chronic electroconvulsive seizures. J. ECT, 1998, 14(3), 181-193. http://dx.doi.org/10.1097/00124509-199809000-00004
50. Yi, L. T., Li, J., Geng, D., Liu, BB., Fu, Y., Tu, J. Q., Liu, Y., Weng LJ. .Essential oil of Perilla frutescens induced change in hippocampal expression of brain-derived neurotrophic factor in chronic unpredictable mild stress in mice. J. Ethnopharmacol., 2013, 147(1), 245-253. http://dx.doi.org/10.1016/j.jep.2013.03.015
51. Xue, W., Zhou, X., Yi, N., Jiang, L., Tao, W., Wu, R., Wang, D,. Jiang, J., Ge, X., Wang, Y., Wu, H., Chen, G. Yueju pill rapidly induces antidepressant-like effects and acutely enhances BDNF expression in mouse brain. Evid-Based Compl. Alt., 2013, 2013, 1-9
52. Wei, X. H., Cheng, X. M., Shen, J. S., Wang, Z. T. Antidepressant effect of Yueju-Wan ethanol extract and its fractions in mice models of despair. J. Ethnopharmacol., 2008, 117(2), 339-344. http://dx.doi.org/10.1016/j.jep.2008.02.004
53. Wei, X. H., Xu, X. D., Shen, J. S., Wang, Z. T. Antidepressant effect of Yueju ethanol extract and its constituents in mice models of despair. China Pharm., 2009, 20(3), 166-168.
54. Thome, J., Sakai, N., Shin, K. H., et al. cAMP response elementmediated gene transcription is upregulated by chronic antidepressant treatment. J. Neurosci., 2000, 20(11), 4030-4036.
55. Nibuya, M., Nestler, E. J., Duman, R. S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci., 1996, 16(7), 2365-2372.
56. Liu, L., Li, B., Zhou, Y., Wang L., Tang F., Shao D., Jiang X., Zhao H., Cui R., Li Y. Antidepressant-like effect of Fuzi total alkaloid on ovariectomized mice. J. Pharmacol. Sci., 2012, 120(4), 280-287. http://dx.doi.org/10.1254/jphs.12163FP
57. Antonijevic, I. A. Depressive disorders-is it time to endorse different pathophysiologies? Psychoneuroendocrinology, 2006, 31(1), 1-15. http://dx.doi.org/10.1016/j.psyneuen.2005.04.004
58. Raison, C. L., Capuron, L., Miller, A. H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol., 2006, 27(1), 24-31. http://dx.doi.org/10.1016/j.it.2005.11.006
59. Ressler, K. J., Nemeroff, C. B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety, 2000, 12(S1), 2-19.
60. Brown, R.P., Gerbarg, P.L., Ramazanov, Z. Rhodiola rosea: a phytomedicinal overview. Herbal Gram, 2002, 56, 40-52.
61. Chen, Q. G., Zeng, Y. S., Qu, Z. Q., Tang JY., Qin YJ., Chung P., Wong R., Hagg U. The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats. Phytomedicine, 2009, 16(9), 830-838. http://dx.doi.org/10.1016/j.phymed.2009.03.011
62. Panossian, A., Hambardzumyan, M., Hovhanissyan, A., Wikman, G. The adaptogens Rhodiola and Schizandra modify the response to immobilization stress in rabbits by suppressing the increase of phosphorylated stress-activated protein kinase, nitric oxide and cortisol. Drug Target Insights, 2007, 2, 39.
63. Shin, I. J., Son, S. U., Park, H., Kim Y., Park SH., Swanberg K., Shin JY., Ha SK., Cho Y., Bang SY., Lew JH., Cho SH., Maeng S. Preclinical Evidence of Rapid-Onset Antidepressant-Like Effect in Radix Polygalae Extract. PloS One, 2014, 9(2), e88617. http://dx.doi.org/10.1371/journal.pone.0088617
64. Hosseinzadeh, H., Karimi, G., Niapoor, M. Antidepressant effect of Crocus sativus L. stigma extracts and their constituents, crocin and safranal, in mice. In Intl. Symposium on Saffron Biol. Biotechnol., 2013, 650 (pp. 435-445).
65. Karimi, G. R., Hosseinzadeh, H., Khalegh, P. P. Study of antidepressant effect of aqueous and ethanolic extract of Crocus sativus in mice. Iran J. Basic Med. Sci., 2001,4, 11-15.
66. Abe, K., Sugiura, M., Shoyama, Y., Saito, H. Crocin antagonizes ethanol inhibition of NMDA receptor-mediated responses in rat hippocampal neurons. Brain Res., 1998, 787(1), 132-138. http://dx.doi.org/10.1016/S0006-8993(97)01505-9
67. Lechtenberg, M., Schepmann, D., Niehues, M., Hellenbrand N., Wunsch B., Hensel A. Quality and Functionality of Saffron: Quality Control, Species Assortment and Affinity of Extract and Isolated Saffron Compounds to NMDA and sigma1 (Sigma-1) Receptors. Planta Med., 2008, 74(7), 764. http://dx.doi.org/ 10.1055/s-2008-1074535
68. Nutt, D. J., Ballenger, J. C., Sheehan, D., Wittchen, H. U. Generalized anxiety disorder: comorbidity, comparative biology and treatment. Int. J. Neuropsychoph., 2002, 5(04), 315-325. http://dx.doi.org/10.1017/S1461145702003048
69. Tyrer, P. and Baldwin, D. Generalised anxiety disorder. Lancet, 2006, 368(9553), 2156-2166. http://dx.doi.org/10.1016/S0140-6736(06)69865-6
70. Toriizuka, K., Kamiki, H., Ohmura, N. Y., Fujii, M., Hori, Y., Fukumura, M., Hirai, Y., Isoda, S., Nemoto, Y., Ida, Y. Anxiolytic effect of Gardeniae Fructus-extract containing active ingredient from Kamishoyosan (KSS), a Japanese traditional Kampo medicine. Life Sci., 2005, 77(24), 3010-3020. http://dx.doi.org/ 10.1016/j.lfs.2004.12.054
71. Krishnakumar, A., Nandhu, M. S., Paulose, C. S. Up regulation of 5-HT 2C receptors in hippocampus of pilocarpine-induced epileptic rats: Antagonism by Bacopa monnieri. Epilepsy Behav., 2009, 16(2), 225-230. http://dx.doi.org/10.1016/j.yebeh.2009.07.031
72. Dirks, A., Groenink, L., Westphal, K. G., Olivier JD, Verdouw PM, van der Gugten J, Geyer MA, Olivier B. Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs. Neuropsychopharmacology, 2003, 28(10), 1790-1798. http://dx.doi.org/10.1038/sj.npp.1300256
73. Groenink, L., Pattij, T., De Jongh, R., Van der Gugten, J., Oosting, RS., Dirks, A., Olivier ,B. 5-HT 1A receptor knockout mice and mice over expressing corticotropin-releasing hormone in models of anxiety. Eur. J. Pharmacol., 2003, 463(1), 185-197. http://dx.doi. org/10.1016/S0014-2999(03)01281-0
74. Di Renzo, G. Ginkgo biloba and the central nervous system. Fitoterapia, 2000, 71, S43-S47. http://dx.doi.org/10.1016/S0367-326X(00)00180-5
75. Van Gaalen, M. M., Stenzel-Poore, M. P., Holsboer, F., Steckler, T. Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur. J. Neurosci., 2002, 15(12), 2007-2015. http://dx. doi.org/10.1046/j.1460-9568.2002.02040.x
76. Deussing, J. M., Wurst, W. Dissecting the genetic effect of the CRH system on anxiety and stress-related behaviour. CR Biol., 2005, 328(2), 199-212. http://dx.doi.org/10.1016/j.crvi.2005. 01.001
77. Strohle, A., Holsboer, F. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry, 2003, 36, S207-S214. http://dx.doi.org/10.1055/s-2003-45132
78. Heilig, M. The NPY system in stress, anxiety and depression. Neuropeptides, 2004, 38(4), 213-224. http://dx.doi.org/10.1016/ j.npep.2004.05.002
79. Heilig, M., Zachrisson, O., Thorsell, A., Ehnvall, A., Mottagui-Tabar, S., Sjogren, M., Asberg, M., Ekman, R., Wahlestedt, C., Agren, H. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with pre pro NPY gene polymorphism. J. Psychiatr. Res., 2004, 38(2), 113-121. http://dx.doi.org/10.1016/ S0022-3956(03)00101-8
80. Awad, R., Levac, D., Cybulska, P., Merali, Z., Trudeau, V.L., Arnason, J.T. Effects of traditionally used anxiolytic botanicals on enzymes of the γ-aminobutyric acid (GABA) system This article is one of a selection of papers published in this special issue (part 1 of 2) on the Safety and Efficacy of Natural Health Products. Can. J. Physiol. Pharm., 2007, 85(9), 933-942. http://dx.doi.org/10.1139/ Y07-083
81. Pearl, P. L., Gibson, K. M. Clinical aspects of the disorders of GABA metabolism in children. Curr. Opin. Neurol., 2004, 17(2), 107-113. http://dx.doi.org/10.1097/00019052-200404000-00005
82. Deng, S., West, B. J., Palu, A. K., Zhou, B. N., Jensen, C. J. Noni as an anxiolytic and sedative: A mechanism involving its gammaaminobutyric acidergic effects. Phytomedicine, 2007, 14(7), 517-522. http://dx.doi.org/10.1016/j.phymed.2007.04.005
83. Murphy, K., Kubin, Z. J., Shepherd, J. N., Ettinger, R. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats. Phytomedicine, 2010, 17(8), 674-678. http://dx.doi.org/ 10.1016/j.phymed.2009.10.020
84. Dietz, B. M., Mahady, G. B., Pauli, G. F., Farnsworth, N. R. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Mol. Brain Res., 2005, 138(2), 191-197. http://dx.doi.org/10.1016/j.molbrainres.2005.04.009
85. Peng, Z. C. and Zhu, J. J. Research advances in chemical constituents and pharmacological effects of semen Ziziphi. Spinosae. Lishizhen Med. Medica Res., 2001, 12, 86-7.
86. Han, H., Ma, Y., Eun, J. S., Li R, Hong JT, Lee MK, Oh KW. Anxiolytic-like effects of sanjoinine A isolated from Zizyphi Spinosi Semen: Possible involvement of GABAergic transmission. Pharmacol. Biochem. Be, 2009, 92(2), 206-213. http://dx.doi.org/ 10.1016/j.pbb.2008.11.012
87. Kumar, D., Bhat, Z. A., Kumar, V., Raja, W. Y., Shah, M. Y. Anti-anxiety activity of Stachys tibetica Vatke. Chin. J. Nat. Med., 2013, 11(3), 240-244. http://dx.doi.org/10.1016/s1875-5364(13) 60022-9
88. Kumar, D., Bhat, Z. A., Kumar, V., Shah, M. Y. Coumarins from Angelica archangelica Linn. and their effects on anxiety-like behavior. Prog. Neuro-Psychoph., 2013, 40, 180-186. http://dx.doi. org/10.1016/j.pnpbp.2012.08.004
89. Bisong, S. A., Brown, R., Osim, E. E. Comparative effects of Rauwolfia vomitoria and chlorpromazine on locomotor behaviour and anxiety in mice. J. Ethnopharmacol., 2010, 132(1), 334-339. http://dx.doi.org/10.1016/j.jep.2010.08.045
90. Shaw, D., Annett, J. M., Doherty, B., Leslie, J. C. Anxiolytic effects of lavender oil inhalation on open-field behaviour in rats. Phytomedicine, 2007, 14(9), 613-620. http://dx.doi.org/10.1016/ j.phymed.2007.03.007
91. Park, J. H., Cha, H. Y., Seo, J. J., Hong JT., Han K., Oh KW. Anxiolytic-like effects of ginseng in the elevated plus-maze model: comparison of red ginseng and sun ginseng. Prog. Neuro-Psychoph., 2005, 29(6), 895-900. http://dx.doi.org/10.1016/j. pnpbp.2005.04.016
92. Ancoli-Israel, S., Roth, T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep, 1999, 22, S347-53.
93. Roth, T., Roehrs, T., Pies, R. Insomnia: pathophysiology and implications for treatment. Sleep Med. Rev., 2007, 11(1), 71-79. http://dx.doi.org/10.1016/j.smrv.2006.06.002
94. Sateia, M.J., Nowell, P.D. Insomnia. Lancet, 2004, 364, 1959-1973. http://dx.doi.org/10.1016/S0140-6736(04)17480-1
95. Shou, C. H., Wang, J., Zheng, X. X., Guo, D. W. Inhibitory effect of jujuboside A on penicillin sodium induced hyperactivity in rat hippocampal CA1 area in vitro. Acta Pharmacol. Sin., 2001, 22(11), 986-990.
96. Wang, C., Xia, Q., Xiong, T., Xia, Y. Upregulation of Mark3 and Rpgrip1 mRNA expression by jujuboside A in mouse hippocampus3. Acta Pharmacol. Sin., 2007, 28(3), 334-338. http://dx.doi.org/ 10.1111/j.1745-7254.2007.00497.x
97. Yi, P. L., Lin, C. P., Tsai, C. H., Lin, J. G., Chang, F. C. The involvement of serotonin receptors in suanzaorentang-induced sleep alteration. J. Biomed. Sci., 2007, 14(6), 829-840. http://dx. doi.org/10.1007/s11373-007-9197-8
98. You, Z. L., Xia, Q., Liang, F. R., Tang, Y. J., Xu, C. L., Huang, J., Zhao, L., Zhang, W. Z, He, J. J. Effects on the expression of GABAA receptor subunits by jujuboside A treatment in rat hippocampal neurons. J. Ethnopharmacol., 2010, 128(2), 419-423. http://dx.doi.org/10.1016/j.jep.2010.01.034
99. Abourashed, E. A., Koetter, U., Brattstrom, A. In vitro binding experiments with a Valerian, Hops and their fixed combination extract (Ze91019) to selected central nervous system receptors. Phytomedicine, 2004, 11(7), 633-638. http://dx.doi.org/10.1016/ j.phymed.2004.03.005
100. Bown, D. The Royal Horticultural Society encyclopedia of herbs & their uses. Dorling Kindersley Limited. 1995.
101. Yakoot, M., Helmy, S., Fawal, K. Pilot study of the efficacy and safety of lettuce seed oil in patients with sleep disorders. Int. J. Gen. Med, 2011, 4, 451. http://dx.doi.org/10.2147/IJGM.S21529
102. Hosseinzadeh, H., Noraei, N. B. Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother. Res., 2009, 23(6), 768-774. http://dx. doi.org/10.1002/ptr.2597
103. Dai, Y., Li, Z., Xue, L., Dou, C., Zhou, Y., Zhang, L., Qin, X. Metabolomics study on the anti-depression effect of xiaoyaosan on rat model of chronic unpredictable mild stress. J. Ethnopharmacol., 2010, 128(2), 482-489. http://dx.doi.org/10.1016/j.jep.2010.01.016
104. Kwon, S., Lee, B., Kim, M., Lee, H., Park, H. J., Hahm, D. H. Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test. Prog. Neuro-Psychoph., 2010, 34(2), 265-270. http://dx.doi.org/10.1016/j.pnpbp.2009.11.015
105. Xiuping, S., Zhe, S., Tengfei, L., et al. Antidepressant-like effects of total saikosaponins of Bupleurum yinchowense in mice. J. Med. Plants Res., 2012, 6(26), 4308-4316. http://dx.doi.org/10.5897/ jmpr12.338
106. Li, X. Q., Song, A. H., Li, W., Chen, X. H., Bi, K. S. Analysis of the fatty acid from Bupleurum chinense DC in China by GC-MS and GC-FID. Chem. Pharm. Bull., 2005, 53(12), 1613-1617. http://dx.doi.org/10.1248/cpb.53.1613
107. Yen, M. H., Lin, C. C., Chuang, C. H., Liu, S. Y. Evaluation of root quality of Bupleurum species by TLC scanner and the liver protective effects of "Xiao-chai-hu-tang" prepared using three different Bupleurum species. J. Ethnopharmacol., 1991, 34(2), 155-165.
108. Kuang, H., Sun, S., Yang, B., Xia, Y., Feng, W. New megastigmane sesquiterpene and indole alkaloid glucosides from the aerial parts of Bupleurum chinense DC. Fitoterapia, 2009, 80(1), 35-38. http://dx.doi.org/10.1016/j.fitote.2008.09.007
109. Zhu, Z., Liang, Z., Han, R., Dong, J. E. Growth and saikosaponin production of the medicinal herb Bupleurum chinense DC. under different levels of nitrogen and phosphorus. Ind. Crop. Prod., 2009, 29(1), 96-101. http://dx.doi.org/10.1016/j.indcrop.2008.04.010
110. Seo, M. K., Song, J. C., Lee, S. J., et al. Antidepressant-like effects of Bupleuri Radix extract. Eur. J. Integr. Med., 2012, 4(4), e392-e399.
111. Liao, J. F., Jan, Y. M., Huang, S. Y., Wang, H.H., Yu, L.L., Chen, C.F. Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs. Proc. Natl. Sci. Council Republic of China. Part B, Life Sci., 1995, 19(3), 151-158.
112. Xiao, P. G. Modern Chinese materia medica. Chem. Industry Press, 2002, 4, 253-272.
113. Liang, Z. B., Liu, L., Chao, Z. Investigation of medicinal Bupleurum resources and current situation of Chaihu production. Lishizhen Med. Materia Res., 2012, 8, 076.
114. Xiuping, S., Zhe, S., Tengfei, L., et al. Antidepressant-like effects of total saikosaponins of Bupleurum yinchowense in mice. J. Med. Plants Res., 2012, 6(26), 4308-4316. http://dx.doi.org/10.5897/ jmpr12.338
115. Li, Z. Y., Guo, Z., Liu, Y. M., Liu X. M., Chang, Q., Liao, Y. H., Pan, R. L. Neuroprotective effects of Total Saikosaponins of Bupleurum yinchowense on corticosterone-induced apoptosis in PC12 cells. J. Ethnopharmacol., 2013, 148(3), 794-803. http://dx.doi.org/ 10.1016/j.jep.2013.04.057
116. Hamburger, M., Marston, A., Hostettmann, K. Search for new drugs of the plant origin. Adv. Drug Res., 1991, 20, 167-217. http://dx.doi.org/10.1016/B978-0-12-013320-8.50007-1
117. Handley, S. L., McBlane, J. W., Critchley, M. A. E., Njung'e, K. Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors. Behav. Brain Res., 1993, 58(1), 203-210. http://dx.doi.org/10.1016/0166-4328(93) 90104-X
118. Chatterjee, S. S., Gabard, B. Studies on mechanism of action of an extract of Ginkgo biloba, a drug used for treatment of ischemic vascular diseases. N-S Arch. Pharmacol., 1982, 320, R52.
119. Krieglstein, J., Beck, T., Seibert, A. Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci, 1986, 39(24), 2327-2334. http://dx.doi.org/10.1016/0024-3205(86) 90663-6
120. Shih, J. C., Chen, K., Ridd, M. J., Seif, I. Ginkgo biloba abolishes aggression in mice lacking MAO A. Antioxid. Redox Sign, 2000, 2(3), 467-471. http://dx.doi.org/10.1089/15230860050192242
121. White, H. L., Scates, P. W., Cooper, B. R. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Sci., 1996, 58(16), 1315-1321. http://dx.doi.org/10.1016/0024-3205(96)00097-5
122. Taylor, J.E. Soc. Neurosci. Ann. Meeting St Louis, 1990 (Abstract No.32.11).
123. Woelk, H., Arnoldt, K. H., Kieser, M., Hoerr, R. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: A randomized, doubleblind, placebo-controlled trial. J. Psychiatr. Res., 2007, 41(6), 472-480. http://dx.doi.org/10.1016/j.jpsychires.2006.05.004
124. Xie, Z.W. Chinese Herbal Medicine Compilation, second ed. The People's Medical Publishing House, Beijing 852pp. 1996.
125. Peng, W. H., Hsieh, M. T., Lee, Y. S., Lin, Y. C., Liao, J. Anxiolytic effect of seed of Ziziphus jujuba in mouse models of anxiety. J. Ethnopharmacol., 2000, 72(3), 435-441. http://dx.doi. org/10.1016/S0378-8741(00)00255-5
126. Hsieh, M. T., Chen, H. C., Kao, H. C., Shibuya, T. Suanzaorentang, and anxiolytic Chinese medicine, affects the central adrenergic and serotonergic systems in rats. Proc. Natil. Sci. Council, Republic of China. Part B. Life Sci., 1986, 10(4), 263-268.
127. Wu, S. X., Zhang, J. X., Xu, T., Li LF., Zhao SY., Lan MY. Effects of seeds, leaves and fruits of Ziziphus spinosa and jujuboside A on central nervous system function. China J. Chinese Materia Medica, 1993, 18(11), 685-7.
128. Saito, K. I., Umeda, S., Kawashima, K., Kano, Y. Pharmacological properties of traditional medicines. XXVI. Effects of Sansohnin-to on pentobarbital sleep in stressed mice. Biol. Pharm. Bull., 2000, 23(1), 76-79. http://dx.doi.org/10.1248/bpb.23.76
129. Shiyi, L. Some basic features of the new sleep-aid tea (SAT) for the treatment of insomnia. Sleep Res. Online: SRO, 1999, 3(2), 49-52.
130. Ma, Y., Han, H., Nam, S. Y., Kim YB., Hong JT., Yun YP., Oh KW. Cyclopeptide alkaloid fraction from Zizyphi Spinosi Semenenhances pentobarbital-induced sleeping behaviors. J. Ethnopharmacol., 2008, 117(2), 318-324. http://dx.doi.org/ 10.1016/j.jep.2008.02.006
131. Wang, L. E., Bai, Y. J., Shi, X. R., Cui XY., Cui SY., Zhang F., Zhang QY., Zhao YY., Zhang YH. Spinosin, a C-glycoside flavonoid from semen Zizhiphi Spinozae, potentiated pentobarbitalinduced sleep via the serotonergic system. Pharmacol. Biochem. Be, 2008, 90(3), 399-403. http://dx.doi.org/10.1016/j.pbb.2008. 03.022
132. Zhao, J., Li, S. P., Yang, F. Q., Li, P., Wang, Y. T. Simultaneous determination of saponins and fatty acids in Ziziphus jujube (Suanzaoren) by high performance liquid chromatographyevaporative light scattering detection and pressurized liquid extraction. J. Chromatogr. A, 2006, 1108(2), 188-194. http://dx. doi.org/10.1016/j.chroma.2005.12.104
133. Zhang, M., Zhang, Y., Xie, J. Simultaneous determination of jujuboside A, B and betulinic acid in semen Ziziphi spinosae by high performance liquid chromatography-evaporative light scattering detection. J. Pharm. Biomed., 2008, 48(5), 1467-1470. http://dx.doi.org/10.1016/j.jpba.2008.09.022
134. Cao, J. X., Zhang, Q. Y., Cui, S. Y., Cui, X. Y., Zhang, J., Zhang, Y. H., Bai, Y. J., Zhao, Y. Y. Hypnotic effect of jujubosides from Semen Ziziphi Spinosae. J. Ethnopharmacol., 2010, 130(1), 163-166. http://dx.doi.org/10.1016/j.jep.2010.03.023
135. Feng, Z. Y., Guo, D. W., Su, S., Zhao, H., Zheng, X. X. Sedative and anticonvulsant effect of jujuboside A. J. Zhejiang Uni.Med. Sci., 2002, 31(2), 103-106.
136. Shin, K. H., Lee, C. K., Woo, W. S., Kang, S. S. Sedative action of spinosin. Arch. Pharm. Res., 1978, 1(1), 7-11. http://dx.doi.org/10. 1007/BF02856299
137. Zhou, Y., Lu, L., Li, Z., Gao X., Tian J., Zhang L., Wu B., Qin X. Antidepressant-like effects of the fractions of Xiaoyaosan on rat model of chronic unpredictable mild stress. J. Ethnopharmacol., 2011, 137(1), 236-244. http://dx.doi.org/10.1016/j.jep.2011.05.016
138. Xiong, J. Y., Zang, N., Zhang, C. Y., Yang, J., Liu, X. S. Studies on the anti-depression effect of Xiaoyao Powder in mice. Pharmacol. Clin. Chinese Materia Medica, 2007, 23, 3-5. http://dx.doi.org/10.1016/j.jep.2011.06.024
139. Gao, X., Zheng, X., Li, Z., Zhou, Y., Sun, H., Zhang, L., Guo, X., Du, G., Qin, X. Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry. J. Ethnopharmacol., 2011, 137(1), 690-699.
140. Peng, X., Zeng, N., Gong, X.P., Gou, L., Liu, J.W. Study on the bdnf/creb signal mechanism of antidepressant effect of xiaoyao powder. Pharmacol. Clin. Chin. Mater. Med., 2012, 28, 9-12.
141. Jia, G. C., Zheng, X. Y., Zhou, Y. Z., Tian, J. S., Qin, X. M. Effects of Xiaoyaosan on chronic unpredictable mild stress model in rats. Chinese J. Exper. Trad. Med. Formulae, 2011, 17, 150-154.
142. Bao, L., Chen, J., Huang, L., Chen, W., Lin, Q., Yao, X. S., Hiroshi, K. Effects of Xiaoyao Wan on the behavioral despair and stress depression mice. J. Chinese Med. Materials, 2008, 31(9), 1360-1364.
143. Wang, T., Qin, F. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Chin. J. Integr. Med., 2010, 8(11), 1075-1079. http://dx.doi.org/10.3736/jcim20101112
144. Pharmacopoeia Committee of China (Eds.), Chinese Pharmacopoeia, Chemical Industry Publishing House, Beijing 2005.
145. Chen, L., Zhang, Q., Yang, G., Fan, L., Tang, J., Garrard, I., Ignatova, S., Fisher, D., Sutherland, I.A. Rapid purification and scale-up of honokiol and magnolol using high-capacity high-speed counter-current chromatography. J. Chromatogr. A, 2007, 1142(2), 115-122. http://dx.doi.org/10.1016/j.chroma.2006.09.098
146. Wang, X., Wang, Y., Geng, Y., Li, F., Zheng, C. Isolation and purification of honokiol and magnolol from cortex Magnoliae officinalis by high-speed counter-current chromatography. J. Chromatogr. A, 2004, 1036(2), 171-175. http://dx.doi.org/10.1016/ j.chroma.2004.02.073
147. Li, J.M., Kong, L.D. Advances in the study on the effect of traditional Chinese medicine on depression and anxiety. China J. Chinese Materia Medica, 2001, 26 (12), 805-807.
148. Ding, D. Z. Clinical use of Banxia-houpu decoction in mental order disease. Chinese Med. Shanxi, 1992, 13(9), 412-413.
149. Luo, L., Nong Wang, J., Kong, L. D., Jiang, Q. G., Tan, R. X. Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula. J. Ethnopharmacol., 2000, 73(1), 277-281. http://dx.doi.org/10.1016/S0378-8741(00)00242-7
150. Guo, Y., Kong, L., Wang, Y., Huang, Z. Antidepressant evaluation of polysaccharides from a Chinese herbal medicine Banxia-houpu decoction. Phytother. Res., 2004, 18(3), 204-207. http://dx.doi.org/ 10.1002/ptr.1394
151. Maruyama, Y., Kuribara, H., Morita, M., Yuzurihara, M., Weintraub, S. T. Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine. J. Nat. Prod., 1998, 61(1), 135-138. http://dx.doi.org/10.1021/np9702446
152. Kuribara, H., Kishi, E., Hattori, N., Yuzurihara, M., Maruyama, Y. Application of the elevated plus-maze test in mice for evaluation of the content of Honokiol in water extracts of magnolia. Phytother. Res., 1999, 13(7), 593-596. http://dx.doi.org/10.1002/(SICI)1099-1573(199911)13:7<593::AID-PTR520>3.0.CO;2-F
153. Kuribara, H., Stavinoha, W. B., Maruyama, Y. Behavioural Pharmacological Characteristics of Honokiol, an Anxiolytic Agent Present in Extracts of Magnolia Bark, Evaluated by an Elevated Plus-maze Test in Mice. J. Pharm. Pharmacol., 1998, 50(7), 819-826. http://dx.doi.org/10.1111/j.2042-7158.1998.tb07146.x
154. Ku, T. H., Lee, Y. J., Wang, S. J., Fan, C. H., Tien, L. T. Effect of honokiol on activity of GAD 65 and GAD 67 in the cortex and hippocampus of mice. Phytomedicine, 2011, 18(13), 1126-1129. http://dx.doi.org/10.1016/j.phymed.2011.03.007
155. Owen, A. The use of Gui Pi Tang in traditional Chinese medicine. 2003.